Skip to main content
. 2019 Jan 24;104(6):1189–1201. doi: 10.3324/haematol.2018.202044

Figure 7.

Figure 7.

H3K79 methylation profiles at genomic loci of MLL targets in MA4-, A4M- and double fusion-expressing human embryonic stem cell-derived blood derivatives. (A) Gene ontology enrichment of differential H3K79me3 peaks specific for double fusion-expressing cells. (B,C) Representative profiles for chromatin immuno-precipitation-sequencing using anti-H3K79me3 antibody at genomic regions of typical non-HOXA (B) and HOXA MLL targets (C).